Endometrial Adenocarcinoma with Concomitant Left Atrial Myxoma by Abaid, Lisa N. et al.
 
Case Rep Oncol 2009;2:150–156 
DOI: 10.1159/000231995 
Published online: August 20, 2009  © 2009 S. Karger AG, Basel 
ISSN 1662–6575 
www.karger.com/cro 
 
 
Bram H. Goldstein, PhD    Gynecologic Oncology Associates, 351 Hospital Road, Suite 507 
Newport Beach, CA 92663 (USA) 
Tel. +1 949 642 5165, Fax +1 949 646 7157, E-Mail bram@gynoncology.com 
 
150
   
Endometrial Adenocarcinoma 
with Concomitant Left Atrial 
Myxoma 
Lisa N. Abaida    Howard D. Epsteinb    Miles Changc    
Rita Kankusa    Bram H. Goldsteina  
aGynecologic Oncology Associates, Hoag Cancer Center, Departments of 
bPathology and cRadiology, Hoag Memorial Hospital Presbyterian, Newport 
Beach, Calif., USA 
 
Key Words 
Endometrial cancer · Atrial myxoma · Co-morbidity · Diagnosis · Treatment 
 
Abstract 
Background: Atrial myxomas are the most common primary heart tumors and 
predominantly considered to be benign lesions.  
Case Study: We report a case involving a 77-year-old woman who presented with a 
pelvic mass. She was found to have a primary endometrial cancer and primary lung 
cancer with concomitant metastatic adrenal gland and mesenteric lesions. Her prior 
medical history also included an untreated 4.0 × 2.0-cm left atrial myxoma which was 
identified on CT scan during the workup of her pelvic mass.  
Results: A clinical decision was made to proceed with surgery for the pelvic mass with a 
subsequent recommendation for left atrial mass resection. Currently, the patient is 
scheduled to begin chemotherapy for primary lung cancer.  
Conclusion: The reported incidence of uterine cancer and a concurrent atrial myxoma is 
very rare. Consequently, the manner and timing in which treatment should be provided 
is imprecise. In the present case, the risk for cardiac complications was high, but given 
the presence of a partial bowel obstruction and the need to diagnose the primary site of 
her metastatic malignancy, the decision was made to proceed with exploratory 
abdominal surgery. 
 
Introduction 
Atrial myxomas are the most common primary heart tumors, accounting for 40–50% 
of primary cardiac tumors [1, 2]. However, the lifetime risk of developing an atrial 
myxoma is approximately 0.02% [3]. Primarily, these lesions are benign, localized and  
Case Rep Oncol 2009;2:150–156 
DOI: 10.1159/000231995 
Published online: August 20, 2009  © 2009 S. Karger AG, Basel 
ISSN 1662–6575 
www.karger.com/cro 
 
 
151
identified within the left atrium. Moreover, atrial myxomas are predominantly quiescent, 
sporadic and discovered as an incidental finding in nearly 20% of cases [4]. 
Conditions associated with atrial myxomas include mitral stenosis, endocarditis, mitral 
regurgitation, and collagen vascular disease [5, 6]. Clinically, patients may experience 
fatigue, dyspnea, angina pectoris and congestive heart failure from obstructed mitral or 
tricuspid valvular blood flow. Studies have also indicated that in approximately 15% of 
atrial myxoma cases, mechanical, valvular heart failure may develop [7, 8]. When cardiac 
death occurs, the event is often attributed to a coronary embolization or a compromised 
(e.g., elderly) health condition. 
Currently, there is scant documentation involving the treatment for an atrial myxoma 
in the context of a recently diagnosed primary uterine cancer [9]. There have been studies 
involving a uterine leiomyoma or leiomyosarcoma either mimicking an atrial myxoma 
[10] or infiltrating the atrium [11, 12], but there have been virtually no clinical cases in 
which an endometrial adenocarcinoma and an atrial myxoma were managed 
concurrently [9]. We report herein the history and complicated treatment of a patient 
affected by these two conditions. 
Case Report 
A 77-year-old (gravida 3, para 3) female presented with a pelvic mass and a partial small bowel 
obstruction in April 2009. She underwent a CT scan of the abdomen and pelvic in the emergency room 
which identified the pelvic lesion in addition to a 6-cm mesenteric mass and a 5-cm left adrenal mass. 
She had no vaginal bleeding. Furthermore, a large lesion was identified in the left atrium, which in 
retrospect was visible on an abdominal CT scan obtained in 2005. The cardiac mass (fig. 1) was 
unchanged between 2005 and 2009. The patient had no cardiac history and was asymptomatic from the 
mass, which was suspected to be a mural thrombus. Her prior medical history included Staph cellulitis 
and acute bronchitis. 
The cardiac mass was evaluated with transesophageal echocardiogram and was found to be a 4-cm 
polypoid lesion originating in the left atrium, which prolapsed across the mitral valve into the left 
ventricle with each heartbeat. Although a biopsy was not performed, the location, appearance, and 
stability supported a diagnosis of atrial myxoma. 
Following cardio-thoracic consultation, prompt open heart surgery with atrial mass resection was 
strongly considered. However, given that the cardiac lesion was symptom-free since 2005 and there 
were immediate concerns regarding a presumed metastatic malignancy and the potential development 
of a complete bowel obstruction, proceeding with abdominal surgery was recommended. 
Prior to the initiation of abdominal surgery, the patient was cleared by cardiology and cardiothoracic 
surgery. Continuous cardiac monitoring during the surgery was employed with a trans-esophageal 
echocardiogram to monitor cardiac function. The patient was aggressively hydrated as the risk of acute 
occlusion of the mitral valve by the mass was felt to be increased in the setting of intravascular volume 
depletion. 
Surgical findings included an enlarged, globoid uterus with no intraperitoneal tumor. The omentum 
was free of disease and the retroperitoneal pelvic and para-aortic lymph nodes were not enlarged. A 6-
cm bulky tumor was found at the root of the mesentery in the proximal jejunum and this was resected 
along with 23 cm of small bowel. The adrenal mass was palpated, found to be minimally mobile, and 
was not resected. An infracolic omentectomy was also performed. 
Frozen section of the uterus at the time of surgery revealed primary endometrial cancer and frozen 
section of the mesenteric mass was thought to be consistent with metastatic endometrial cancer (fig. 2). 
However, on final pathology the mesenteric mass was identified as a poorly differentiated carcinoma, 
immunohistochemically distinct from the uterine carcinoma, and consistent with a pulmonary or 
gastrointestinal primary (fig. 3). 
Postoperatively, the patient underwent a mammogram, colonoscopy and upper GI endoscopy, 
which were normal. A subsequent PET scan exhibited mediastinal adenopathy and this, combined with  
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the immunohistochemical stains, the pattern of metastatic spread, and the patient’s extensive smoking 
history, supports a primary lung cancer. 
Conclusion 
Endometrial cancer is the fourth most frequent cause of cancer in US women, 
accounting for nearly 7,470 deaths in 2008 [13]. While this condition is relatively 
uncommon, the reported coexistent incidence of endometrial cancer and an atrial 
myxoma is extremely rare. Consequently, the precise method in which to approach 
patient management can be very complicated for physicians [9]. 
In patients with an atrial myxoma, one of the primary concerns is the potential for a 
thromboembolic event. Embolism occurs in about 30–40% of patients, which may result 
in transient ischemic attack, stroke, or seizure [5, 8]. Endometrial adenocarcinoma 
patients are typically diagnosed with stage 1 disease, but the lesions can be more 
aggressive, and periodically are associated with metastases, lymphatic involvement and 
secondary conditions, such as a bowel obstruction [14]. The most common presenting 
symptom of endometrial cancer is vaginal bleeding, which interestingly was not reported 
by this patient. 
In the present case study, the clinical decision was deliberated upon and corroborated 
with cardio-thoracic surgery consultation. The deciding factor in initially treating the 
endometrial cancer reflected the concern for a metastatic malignancy and the quiescent 
nature of the cardiac lesion. Moreover, prompt and aggressive treatment is a primary 
tenet in oncology standard of care [14]. 
In addition to the patient’s very rare and complicated condition, the fact that she was 
also afflicted with metastases from a presumed primary lung cancer is noteworthy. 
Following gynecologic surgery, the patient was recovering without incident. 
Unfortunately, further postoperative imaging revealed brain metastases, presumably from 
the primary lung cancer. We suspect that this likely contributed to her intractable nausea, 
which persisted after resection of her mesenteric mass. The plan is for the patient to 
complete chemotherapy and brain radiation, at which point resection of her cardiac mass 
would be considered. However, because of the woman’s advanced age, precarious medical 
condition, and stage 4 lung cancer, her long-term outcome is unfavorable. 
There have been previously reported studies involving a uterine leiomyoma or 
leiomyosarcoma extending into or simulating an atrial myxoma [10–12, 15]. 
Nevertheless, we were only able to identify one reported case documenting the treatment 
for both primary uterine cancer and an atrial myxoma [9]. Barlow et al. [9] described a 
patient who presented with a 2 × 2-cm polypoid myxoid uterine lesion. Frozen section 
revealed lack of nuclear atypia and mitotic activity, consistent with a benign, myxoid 
leiomyoma. Following further evaluation, the patient was diagnosed with a right 4-cm 
intra-atrial myxoma. Due to the size of the cardiac lesion and the patient’s reported 
episodic dizziness and syncope, the atrial myxoma was immediately resected. One month 
later, she was admitted for abdominal surgery to remove the uterine lesion. 
Currently, the reported concurrent incidence of primary uterine cancer and an atrial 
myxoma is very rare. Therefore, reconciling the manner and order in which to treat these 
two diseases presents considerable clinical difficulty [9]. A physician team comprising 
gynecologic oncology, cardio-thoracic surgery and cardiology should collaborate in 
determining optimal patient management. Regrettably, even with prompt and 
comprehensive treatment, there is a significant risk for patient morbidity and mortality.  
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Fig. 1. The atrial myxoma is seen as a large soft tissue mass arising from the left atrium and extending 
though the mitral valve into the lumen of the left ventricle. 
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Fig. 2. The endometrial tumor was low-grade and comprised glandular characteristics of endometrial 
carcinoma. The tumor was also positive for estrogen receptors and negative for carcinoembryonic 
antigen (CEA) and thyroid transcription factor (TTF-1, which is distinctively positive in lung 
adenocarcinomas and thyroid carcinomas). 
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Fig. 3. The mesenteric tumor was high-grade, exhibited nerve infiltration, and formed sheets with 
necrosis. The tumor staining was negative for estrogen receptors, but positive for carcinoembryonic 
antigen (CEA) and thyroid transcription factor (TTF-1, characteristically positive in lung 
adenocarcinomas and thyroid carcinomas). 
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